Does J1010 require prior authorization?

No, J1010 does not require prior authorization (high confidence). Covered without prior authorization.

What is the Medicare reimbursement rate for J1010?

Medicare facility rate: N/A. Non-facility rate: N/A. Work RVU: 0.00.

Backwork Sign up free

`J1010`, Injection, methylprednisolone acetate, 1 mg

HCPCS/CPT

Prior Authorization

No Prior Auth Required

Covered without prior authorization (high confidence)

Medicare Pricing

Work RVU

0.00

Facility

N/A

Non-Facility

N/A

Documentation Required

The medical record must document all non-invasive treatments attempted (e.g., medications, physical therapy, activity modification, home exercise) and the results of those treatments prior to triggering coverage for injections.
If non-invasive treatments are contraindicated, the medical record must state the specific contraindication and why the trigger point is not amenable to other therapeutic modalities.

Medical record must include a detailed history and thorough physical examination documenting diagnostic features (onset/presumed cause, distribution consistent with referral pattern, ROM restriction, muscular deconditioning, focal tenderness, palpable taut band, taut response to snapping palpation, reproduction of referred pain).

Documentation must show failure of conservative care when applicable, or document the rationale for use as bridging therapy or single therapeutic maneuver; this rationale must be available upon Contractor request.

Key Coverage Criteria

Trigger point injections are medically reasonable and necessary for treatment of trigger points that are unresponsive to an adequate trial of non-invasive therapies.
Trigger point injections are covered when non-invasive treatments are contraindicated and the medical record documents the contraindication.
Trigger point injections may be used when trigger point pain is severe and unresponsive to non-invasive treatment modalities.
Trigger point injection is covered for established myofascial pain syndrome (MPS) after diagnosis is documented by a detailed history and thorough physical examination.
Trigger point injection is covered when noninvasive medical management has been unsuccessful (examples: analgesics, passive physical therapy, ultrasound, range of motion and active exercises).
Trigger point injection is covered as a bridging therapy to relieve pain while other treatments (e.g., medication or physical therapy) are initiated, or as a single therapeutic maneuver, when documented rationale is present in the medical record.

6 Active Policies

FIRST_COAST-L33912, Trigger Point Injections

FIRST_COAST-L40314, Trigger Point Injections

NOVITAS-JH-L40310, Trigger Point Injections

NOVITAS-JH-L35010, Trigger Point Injections

NOVITAS-JL-L35010, Trigger Point Injections

NOVITAS-JL-L40310, Trigger Point Injections

`J1010`, Injection, methylprednisolone acetate, 1 mg

Prior Authorization

Medicare Pricing

Documentation Required

Key Coverage Criteria

6 Active Policies

Related Codes

Have a follow-up question?

J1010, Injection, methylprednisolone acetate, 1 mg

Prior Authorization

Medicare Pricing

Documentation Required

Key Coverage Criteria

6 Active Policies

Related Codes

Have a follow-up question?

`J1010`, Injection, methylprednisolone acetate, 1 mg